Elucida Oncology, Inc. of Monmouth Junction, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-22. The offering totals $30.0M, of which $10.9M was reported sold. Industry: Biotechnology.
Showing 25 of 29 people.
| Name | Role | Location |
|---|---|---|
| Isaac A Blech | Director | CITY OF INDUSTRY, CA |
| Tim A Boris | Director | DURHAM, NC |
| Michelle A Bradbury | Director | New York, NY |
| Steven Larson | Director | New York, NY |
| Sigurdur A Olafsson | Director | New York, NY |
| Edward Rosen | Director | New York, NY |
| Edward Rosen | Executive Officer | New York, NY |
| Michael Smith | Director | Austin, TX |
| Teresa Ressel | Director | Philadelphia, PA |
| Robert Ruffolo | Director | Boston, MA |
| Robert Essner | Director | Sarasota, FL |
| Robert Essner | Executive Officer | Sarasota, FL |
| Gary Sender | Director | Bryan, TX |
| Tim Boris | Director | Raleigh, NC |
| David Zacardelli | Director | Monmouth Junction, NJ |
| Ulrich Wiesner | Director | Monmouth Junction, NJ |
| Natalie MacDonald | Director | Monmouth Junction, NJ |
| Geno Germano | Director | Monmouth Junction, NJ |
| Geno Germano | Executive Officer | Monmouth Junction, NJ |
| Kai Ma | Executive Officer | Monmouth Junction, NJ |
| Eliel Bayever | Executive Officer | Monmouth Junction, NJ |
| Somaiya Ian | Executive Officer | Monmouth Junction, NJ |
| Gregory Adams | Executive Officer | Monmouth Junction, NJ |
| Michael T Smith | Director | Arlington, VA |
| Robert A Ruffolo | Director | New York, NY |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2023-08-03 | D/A | $22.3M | $22.3M |
| 2023-06-15 | D | $40.0M | $22.9M |
| 2022-03-28 | D | $22.3M | $22.3M |
| 2021-01-12 | D/A | $35.0M | $35.0M |
| 2020-12-29 | D/A | $35.0M | $32.6M |
| 2020-12-10 | D/A | $35.0M | $27.2M |
| 2020-11-10 | D | $35.0M | $17.7M |
| 2020-06-04 | D/A | $30.0M | $8.8M |
| 2020-05-26 | D | $30.0M | $7.4M |
| 2019-02-07 | D/A | $30.0M | $28.8M |
| 2019-01-03 | D/A | $30.0M | $28.1M |